SCHEMBL18069191

SCHEMBL18069191

CCCCC#Cc1ccc2c3c(cccc13)C(=O)N(OS(=O)(=O)CCCC)C2=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 6/20 0.40
▸ TDP1 Q9NUW8 2/20 0.39
▸ MEN1 O00255 6/20 0.38
▸ KMT2A Q03164 6/20 0.38
▸ MAPT P10636 4/20 0.38
▸ L3MBTL1 Q9Y468 3/20 0.38
▸ POLB P06746 2/20 0.38
▸ USP2 O75604 3/20 0.36
▸ ATM Q13315 2/20 0.36
▸ HTT P42858 2/20 0.36
▸ MAPK1 P28482 2/20 0.36
▸ RGS12 O14924 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ TLR9 Q9NR96 1/20 0.36
▸ KDM4E B2RXH2 5/20 0.34
▸ ALDH1A1 P00352 5/20 0.34
▸ HPGD P15428 3/20 0.34
▸ CYP1B1 Q16678 2/20 0.34
▸ KEAP1 Q14145 2/20 0.34
▸ NFE2L2 Q16236 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24454813 0.92 TDP1 (0.34) BRD4TDP1MEN1KMT2AMAPT
SCHEMBL18069175 0.89 TDP1 (0.40) BRD4TDP1MEN1KMT2AMAPT
SCHEMBL18069178 0.86 MEN1 (0.39) BRD4TDP1MEN1KMT2AMAPT
SCHEMBL18069183 0.85 TDP1 (0.39) BRD4TDP1MEN1KMT2AMAPT
SCHEMBL18069145 0.82 MAPT (0.53) BRD4TDP1MEN1KMT2AMAPT
SCHEMBL18069148 0.82 KCNH2 (0.42) BRD4TDP1MEN1KMT2AMAPT
SCHEMBL18069146 0.82 KCNH2 (0.42) BRD4TDP1MEN1KMT2AMAPT
SCHEMBL18069147 0.82 KCNH2 (0.42) BRD4TDP1MEN1KMT2AMAPT
SCHEMBL19015042 0.82 TDP1 (0.41) BRD4TDP1MEN1KMT2AMAPT
SCHEMBL18069140 0.82 TDP1 (0.34) BRD4TDP1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9709886-B2 Sulfonic acid derivative compounds as photoacid generators in resist applications Heraeus Precious Metals North America Daychem LLC (US) 2017-07-18 — — US disclosed
US-9709886-B2 Sulfonic acid derivative compounds as photoacid generators in resist applications Heraeus Precious Metals North America Daychem LLC (US) 2017-07-18 — — US disclosed
US-20170003587-A1 SULFONIC ACID DERIVATIVE COMPOUNDS AS PHOTOACID GENERATORS IN RESIST APPLICATIONS HERAEUS EPURIO LLC 2017-01-05 — — US disclosed
US-20170003587-A1 SULFONIC ACID DERIVATIVE COMPOUNDS AS PHOTOACID GENERATORS IN RESIST APPLICATIONS HERAEUS EPURIO LLC 2017-01-05 — — US disclosed
US-9477150-B2 Sulfonic acid derivative compounds as photoacid generators in resist applications Heraeus Precious Metals North America Daychem LLC (US) 2016-10-25 — — US disclosed
US-9477150-B2 Sulfonic acid derivative compounds as photoacid generators in resist applications Heraeus Precious Metals North America Daychem LLC (US) 2016-10-25 — — US disclosed
US-20160266487-A1 SULFONIC ACID DERIVATIVE COMPOUNDS AS PHOTOACID GENERATORS IN RESIST APPLICATIONS HERAEUS EPURIO LLC 2016-09-15 — — US disclosed
US-20160266487-A1 SULFONIC ACID DERIVATIVE COMPOUNDS AS PHOTOACID GENERATORS IN RESIST APPLICATIONS HERAEUS EPURIO LLC 2016-09-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160266487-A1 SULFONIC ACID DERIVATIVE COMPOUNDS AS PHOTOACID GENERATORS IN RESIST APPLICATIONS ALAD, MPST, ASIC1 BRD4 3666/4885TDP1 4387/4885MEN1 1317/4885
US-20170003587-A1 SULFONIC ACID DERIVATIVE COMPOUNDS AS PHOTOACID GENERATORS IN RESIST APPLICATIONS ALAD, MPST, ASIC1 BRD4 3666/4885TDP1 4387/4885MEN1 1317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback